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Abstract
Introduction: The pathophysiology of inflammatory bowel 
disease (IBD) is incompletely understood. Current concepts 
imply that environmental factors (EFs) trigger disease onset 
as well as flares in genetically susceptible individuals. Objec-
tive: The objective of this study is to analyze the association 
between IBD and various EFs, which may influence the 
pathogenesis of the disease. Methods: 2,294 patients from 
the Swiss IBD Cohort Study (SIBDCS) received a question-
naire regarding EF including mode of delivery, breastfeed-
ing, animals in household, and place of residence. The con-
trol group comprised patients’ childhood friends, who grew 
up in a similar environment (“friends cohort”). Results: A to-
tal of 1,111 questionnaires were returned from SIBDCS pa-
tients (response rate: 48.4%). Breastfeeding for <6 months 
was associated with a decreased risk for ulcerative colitis/
indeterminate colitis (UC/IC) (OR: 0.473, p = 0.006). IBD pa-
tients reported less pet animals in the household than the 
control group (p = 0.004). The presence of cats or dogs (OR: 
0.688, p = 0.015) and pet rodents (OR: 0.598, p = 0.001) in the 
household before the age of 20 was inversely associated 
with the risk for UC/IC. Conclusion: The present study under-
lines the importance of EFs in the pathogenesis of IBD. Over-
all, the development of UC/IC seems to be more affected 
from environmental influences than from Crohn’s disease. 
Our results imply a protective effect of possessing pet ani-
mals in household and short breastfeeding regarding the 
onset of UC/IC. © 2020 The Author(s)
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Introduction
Inflammatory bowel diseases (IBD) are chronic im-
mune-mediated diseases of the gastrointestinal tract, 
which can be subclassified into Crohn’s disease (CD), ul-
cerative colitis (UC), and indeterminate colitis (IC).
In population-based studies, the incidence and preva-
lence of IBD in Europe and the USA have been on the rise 
since the beginning of the 20th century [1, 2]. Moreover, in 
Asian regions, for example, in countries like China, India, 
or Indonesia, both prevalence and incidence of CD and UC 
also increased continuously over the last 30 years [3].
Current concepts of IBD pathogenesis imply deregula-
tion of host immune responses and changes in intestinal 
microbiota in genetically susceptible individuals [4, 5]. 
More than 240 single nucleotide polymorphisms associ-
ated with IBD risk have been identified, but even in com-
bination, they only partially explain IBD risk [6–9]. Fur-
ther, genetic susceptibility does not explain the increase 
of IBD in the last 100 years, because genetic risk factors 
have been present in humans since thousands of years.
A number of environmental factors (EFs) have been 
implicated in the pathogenesis of IBD [10]. There is an 
association between Westernized lifestyle and the in-
crease in CD and UC in the Western world and in Asian 
countries [2, 3]. However, which factors of modern life-
style really contribute to IBD risk remain to be elucidated. 
A frequently discussed concept, the “hygiene hypothesis,” 
postulates that improvements in hygiene result in re-
duced microbial exposure, thus reducing the natural 
training of the immune system and enhancing the risk for 
immune-mediated diseases [11–14]. A non-exclusive 
concept, the “microflora hypothesis,” suggests that 
changes in the composition of the microbiota, for in-
stance, due to diet or use of antibiotics, disrupt microbial-
mediated mechanisms of immunological tolerance [15].
Knowledge about environmental triggers of IBD might 
enable preventive efforts to reduce the incidence of IBD and 
enhance treatment of this disease. However, identifying 
causative EFs that influence the onset of IBD turned out to 
be challenging because potential risk factors may affect pa-
tients for years or decades before the diagnosis of the dis-
ease. In such a scenario, an early environmental insult would 
lead to a subclinical intestinal inflammation, which can be 
present long before occurrence of the first IBD symptoms 
[16]. Long-term prospective observational cohorts (e.g., the 
Swiss IBD Cohort Study, SIBDCS [17]) are well suited to 
identify or confirm potential environmental triggers.
Breastfeeding has been associated with protection 
from IBD, but some controversy remains in the literature 
[18–22]. A recently published review from Ananthakrish-
nan et al. [23] reported a protective effect of breastfeeding 
for both CD and UC. As Cesarean section (C-section) 
strongly affects the infant microbiota, an association be-
tween C-section and IBD risk has been postulated [24–
26]. On the contrary, a population-based study of Bern-
stein et al. [27] reported no association between the mode 
of delivery and IBD. Further, having pets, exposure to 
farm animals, >2 siblings, and a shared bedroom are in-
versely associated with the risk of IBD [28].
Interestingly, an increase in occurrence of CD and UC 
in closely inhabited areas is well described in a recent 
publication [29]. Urbanization describes a process of a 
population shift from a rural to an urban way of life and 
therefore expansions of cities and alterations in lifestyle, 
which constitute a predisposition to immune-mediated 
diseases, such as IBD. In this study, we analyzed SIBDCS 
data to test whether urbanism, breastfeeding, C-section, 
or pet animals are associated with the risk of developing 
IBD in Swiss patients.
Methods
Study Design
We used data from the SIBDCS and 2 related cohorts of pa-
tients’ friends and mothers to evaluate the impact of various EFs 
on IBD risk. SIBDCS is a nationwide prospective cohort study es-
tablished in 2006 and has included patients diagnosed with IBD 
from all parts of Switzerland.
Since the beginning of data collection, clinical and treatment 
data have been prospectively captured once a year and entered into 
a database. SIBDCS is funded by the Swiss National Science Foun-
dation. Purposes and methodology of SIBDCS have been described 
by Pittet et al. [17].
Questionnaires in Swiss national languages were distributed to 
adult IBD patients (n = 2,294) addressing mode of delivery, dura-
tion of breastfeeding, pets in household, and places of residence 
since birth. Identical questionnaires were distributed to up to 3 
matched childhood friends who grew up in a similar environment 
(i.e., “friends cohort”), which serves as a control group. Further-
more, questionnaires addressing the patient’s early childhood 
were filled by the mothers of the patients.
In case of discrepancies between mothers’ and patients’ answers, 
the input from the mothers was used. Questionnaires were sent out 
between December 2015 and October 2016. We included all ques-
tionnaires returned until January 2018 in the present analysis.
Patients were asked in the questionnaire if they currently pos-
sess pet animals or owned pets in the past. As well, we asked the 
patients to declare in which timeframe they were obtaining ani-
mals and tried to pick those out who were in contact with pet ani-
mals before the age of 20. Thus, with an interquartile range of age 
of 20–38 years at the time of diagnosis for CD and 24–41 years for 
UC/IC, we get an insight into the period before the outbreak of the 
disease of most patients and try to identify if different sorts of do-
mesticated animals influence the pathogenesis of IBD.
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To investigate if duration of breastfeeding has an impact on the 
onset of IBD, we created 2 subgroups of >6 months and <6 months 
being breastfed. For our analysis, we defined “urban” as living for 
≥10 years in a city with at least 100,000 inhabitants, allowing the 6 
biggest cities in Switzerland to be included. If not indicated other-
wise, the time period before the age of 20 was considered.
In the final analysis, patients and friends were matched for age 
and sex. However, other potential confounders like socioeconom-
ic status or place of residence have not been matched in the analy-
sis. Further, for the analysis of a specific parameter, urban or rural 
living, breastfeeding, C-section or pet animals in household were 
also not matched for the remaining parameters as this would have 
decreased the sample size too much.
Statistical Analysis
All statistical analyses were performed using the Stata Software 
(v. 14.2; Statacorp, College Station, TX, USA). Baseline demo-
graphics and clinical data were described. Continuous data distri-
bution was assessed using Normal QQ-plot. Gaussian distributed 
data were summarized as mean, SD, and range, while non-Gauss-
ian distributed data were summarized as median, interquartile 
range, and range. Categorical data were summarized as raw fre-
quencies and relative percentages. Differences in means for Gauss-
ian distributed data were assessed using the Student’s t test. Differ-
ences in distribution for non-Gaussian distributed data were as-
sessed using the Mann-Whitney-Wilcoxon rank sum test. 
Differences in distributions for categorical variables were assessed 
Table 1. Clinical characteristics of the study population
CD (n = 617) UC/IC (n = 494) Controls (n = 352)
Gender
Male 274 (44.4) 249 (50.4) 114 (32.4)
Female 343 (55.6) 245 (49.6) 238 (67.6)
Age, year (median, IQR, range) 48, 35–60 (19–87) 49, 38–59 (19–90) 35, 28–45 (18–75)
Age at diagnosis, year (median, IQR, range) 27, 20–38 (1–78) 31, 24–41 (8–78)
Disease duration, year (median, IQR, range) 16, 9–25 (0–53) 13, 8–21 (0–59)
Smoking status at diagnosis
Non-smoker 364 (59.0) 371 (75.1)
Smoker 230 (37.3) 96 (19.4)
Unknown 23 (3.7) 27 (5.5)
Current smoking status
Non-smoker 461 (74.7) 419 (84.8)
Smoker 153 (24.8) 69 (14.0)
Unknown 3 (0.5) 6 (1.2)
Therapy history (ever treated with)
5-ASA 377 (61.1) 474 (96.0)
Antibiotics 116 (18.8) 54 (10.9)
Steroids 537 (87.0) 404 (81.8)
Immunomodulators 499 (80.9) 304 (61.5)
Anti-TNF 387 (62.7) 173 (35.0)
Calcineurin inhibitors 13 (2.1) 47 (9.5)
Extraintestinal manifestation
Any 389 (63.0) 225 (45.5)
Arthritis 338 (54.8) 176 (35.6)
Uveitis/iritis 81 (13.1) 32 (6.5)
Pyoderma gangrenosum 8 (1.3) 10 (2.0)
Erythema nodosum 60 (9.7) 16 (3.2)
Aphthous/oral ulcers 94 (15.2) 25 (5.1)
Ankylosing spondylitis 38 (6.2) 17 (3.4)
Primary sclerosing cholangitis 8 (1.3) 15 (3.0)
Complications
Perianal fistula 168 (27.2) –




Intestinal surgery 260 (42.1) 47 (9.5)
Fistula or abscess surgery 151 (24.5) –
CD, Crohn’s disease; UC, ulcerative colitis; IC, indeterminate colitis.
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using the χ2 test, or the Fisher exact test in case of smaller sample 
size.
To study the association between EFs and the incidence of IBD, 
a case-control analysis was done. IBD patients and controls were 
matched according to age and sex, and a logistic regression model 
was used. Odds ratios (ORs) and 95% confidence intervals (CIs) were 
reported. A p value <0.05 was considered as statistically significant.
Results
Clinical Characteristics of the Study Population
Out of 2,294 questionnaires sent to SIBDC patients, 
1,111 questionnaires were returned (response rate: 
48.4%). In addition, for 305 out of 1,111 responding pa-
tients, mother-filled questionnaires were available (re-
sponse rate: 27.5%). Further, from 225 out of 1,111 re-
sponding patients, we received questionnaires from at 
least 1 patients’ friend (response rate: 20.3%). As we ac-
cepted multiple friend-questionnaires per patient, 352 re-
turned questionnaires from friends could be included.
In total, we received questionnaires from 466 patients 
with UC, 28 with IC, and 617 with CD. Epidemiological 
parameters and data for the clinical history of UC/IC and 
CD patients are depicted in Table 1 and are consistent 
with a mixed cohort of IBD patients with mild, moderate, 
and severe disease.
Breastfeeding
Breastfeeding was significantly lower for UC/IC pa-
tients than for CD patients (UC/IC: 298/494, 72.3% vs. 







p value CD 
versus UC/IC
p value IBD 
versus controls
Breastfeeding
No 112 (21.9) 114 (27.7) 80 (25.2) 0.042 0.803
Yes 400 (78.1) 298 (72.3) 238 (74.8)
Breastfeeding duration
<6 months 138 (62.4) 81 (56.6) 125 (71.0) 0.270 0.014
>6 months 83 (37.6) 62 (43.4) 51 (29.0)
Cesarean section
No 502 (91.4) 406 (93.1) 286 (85.4) 0.329 <0.001
Yes 47 (8.6) 30 (6.9) 49 (14.6)
Any animals in household
No 121 (20.3) 120 (25.2) 53 (15.3) 0.058 0.004
Yes 474 (79.7) 356 (74.8) 294 (84.7)
Cats or dogs in household
No 165 (27.5) 159 (32.9) 97 (28.0) 0.051 0.491
Yes 436 (72.6) 324 (67.1) 250 (72.0)
Pet rodents in household
No 346 (59.0) 291 (61.5) 168 (48.8) 0.413 <0.001
Yes 240 (41.0) 182 (38.5) 176 (51.2)
Birds in household
No 453 (77.6) 346 (73.5) 275 (80.7) 0.122 0.061
Yes 131 (22.4) 125 (26.5) 66 (19.3)
Reptiles in household
No 551 (95.3) 447 (96.1) 314 (92.4) 0.527 0.016
Yes 27 (4.7) 18 (3.9) 26 (7.6)
Fish in household
No 489 (84.2) 399 (85.4) 278 (81.5) 0.569 0.161
Yes 92 (15.8) 68 (14.6) 63 (18.5)
At least 10 years in city >100,000 
inhabitants
No 492 (88.7) 402 (91.4) 333 (94.6) 0.159 0.007
Yes 63 (11.4) 38 (8.6) 19 (5.4)
CD, Crohn’s disease; UC, ulcerative colitis; IC, indeterminate colitis.
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CD: 400/617, 78.1%; p = 0.042; Table  2). However, 
breastfeeding rates for controls (238/352 individuals, 
74.8%) was similar to those for IBD patients. While du-
ration of breastfeeding did not differ between UC and 
CD patients, more controls reported a shorter duration 
of breastfeeding (<6 months) than IBD patients (p = 
0.014).
In the multivariate analysis, breastfeeding was neither 
associated with the risk of IBD (OR: 1.145, 95% CI: 0.789–
1.660, p = 0.476) nor with the risk of CD or UC/IC. There 
was also no significant association of long breastfeeding 
(>6 months) with a diagnosis of IBD, CD, or UC. Shorter 
breastfeeding (<6 months) was also not associated with 
IBD or CD but was a protective factor for the develop-
ment of UC/IC (OR: 0.473, 95% CI: 0.278–0.807, p = 
0.006).
Cesarean Delivery
A similar fraction of CD patients (47 out of 549 pa-
tients, 8.6%) and UC/IC patients (30 out of 436 patients, 
6.9%) were born by C-section (p = 0.329). However, the 
number of control individuals born by C-section (49/335, 
14.6%) was almost twice as high compared to IBD pa-
tients (p < 0.001). In a multivariate analysis, we observed 
no association between cesarean delivery and the devel-
opment of IBD (OR: 0.878, 95% CI: 0.561–1.374, p = 
0.569), UC/IC or CD (Table 2).
Pets and Other Household Animals
474 (79.7%) CD patients and 356 (74.8%) UC/IC pa-
tients reported any animal in the household. This number 
was even higher in the control group (IBD: 830/1,071, 
77.5%; controls: 294/347, 84.7%; p = 0.004). In a multi-
Table 3. Multivariate analysis of the association between environmental risk factors and IBD
Outcome: IBD Outcome: CD Outcome: UC/IC
Breastfeeding 1.145 (0.789–1.660) 1.176 (0.810–1.707) 0.795 (0.558–1.134)
p = 0.476 p = 0.393 p = 0.206
Breastfeeding duration
None (ref) 1.000 1.000 1.000
<6 months 0.698 (0.464–1.051) 0.939 (0.577–1.530) 0.473 (0.278–0.807)
p = 0.085 p = 0.800 p = 0.006
>6 months 1.231 (0.769–1.969) 1.453 (0.833–2.535) 1.024 (0.574–1.824)
p = 0.387 p = 0.188 p = 0.937
Cesarean section 0.878 (0.561–1.374) 0.941 (0.565–1.567) 0.784 (0.421–1.458)
p = 0.569 p = 0.814 p = 0.442
Any animals in household 0.914 (0.608–1.374) 0.767 (0.516–1.141) 0.602 (0.410–0.884)
p = 0.666 p = 0.191 p = 0.010
Cats or dogs in household 1.155 (0.824–1.619) 1.215 (0.865–1.706) 0.825 (0.596–1.142)
p = 0.403 p = 0.261 p = 0.246
Pet rodents in household 0.949 (0.703–1.280) 0.880 (0.652–1.187) 0.671 (0.496–0.907)
p = 0.732 p = 0.402 p = 0.009
Birds in household 1.529 (1.066–2.192) 1.277 (0.885–1.844) 1.778 (1.247–2.536)
p = 0.021 p = 0.192 p = 0.001
Reptiles in household 0.640 (0.340–1.202) 0.715 (0.388–1.318) 0.442 (0.219–0.891)
p = 0.165 p = 0.282 p = 0.022
Fish in household 0.981 (0.665–1.445) na 0.849 (0.570–1.263)
p = 0.921 p = 0.418
At least 10 years in urban areas >100,000 inhabitants 1.815 (1.011–3.259) 1.885 (0.981–3.625) 1.609 (0.759–3.409)
p = 0.046 p = 0.057 p = 0.215
Odds ratio, 95% confidence interval, and p values are reported. IBD, inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative 
colitis; IC, indeterminate colitis.
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variate analysis, the presence of any animal or specific 
animals like cats or dogs, pet rodents, reptiles, or fish did 
not increase the risk for IBD. The presence of birds was 
associated with an increased risk for IBD compared to 
matched controls in the IBD group (OR: 1.529, CI: 1.066–
2.192, p = 0.021). Interestingly, nearly all trends were 
stronger in the subgroup with UC/IC and reached statis-
tical significance for any animal (OR: 0.602, CI: 0.410–
0.884, p = 0.01) and in the subanalysis for pet rodents 
(OR: 0.671, CI: 0.496–0.907, p = 0.009) and reptiles (OR: 
0.442, CI: 0.219–0.891, p = 0.022). The increased risk as-
sociated with birds was also stronger in the subgroup with 
UC (OR: 1.778, CI: 1.247–2.536, p = 0.001). No significant 
association was observed in the subgroup with CD.
These results remained robust when only animals in 
the household in infancy, childhood, or youth of the pa-
tient (i.e., <20 years) were considered (Table 4). For the 
IBD group, in the multivariate analysis, birds increased 
IBD risk compared to matched controls (OR: 1.737, CI: 
1.198–2.520, p = 0.004), but no significant associations 
for other animals were observed. Most trends were also 
stronger in the subgroup with UC/IC (e.g., for any ani-
mal: OR: 0.687, CI: 0.495–0.954, p = 0.025; cats and dogs: 
OR: 0.688, CI: 0.510–0.930 p = 0.015; rodents: OR: 0.598, 
CI: 0.437–0.817, p = 0.001; and birds: OR: 1.671, CI: 
1.151–2.427, p = 0.007), but no significant association in 
the subgroup with CD was observed.
Urban versus Rural Life
A similar number of CD and UC/IC patients lived for 
at least 10 years in a city with >100,000 inhabitants (CD: 
63, 11.4%; UC: 38, 8.6%, n.s.). In contrast, a significantly 
lower number of individuals from the control group re-
ported to have lived in urban places (IBD: 101, 11.2%, 
control: 19, 5.4%, p = 0.007). This risk for IBD for urban 
individuals remained significant in a multivariate analy-
sis (OR: 1.815, CI: 1.011–3.259, p = 0.046). A similar trend 
was observed for the subgroups of CD and UC/IC pa-
tients, which failed to reach statistical significance (Ta-
ble 3).
Urban environment in infancy, childhood, and youth 
of the patient (before age 20) was not significantly associ-
ated with the risk of IBD, CD, or UC (Table 4). While all 
ORs for urbanism in young life also pointed toward an 
increased risk, effect sizes were much smaller than those 
in the previous analysis, considering the whole life (Ta-
ble 3) and none of the associations were significant.
Discussion
Using data from 1,111 IBD patients, we aimed to iden-
tify EFs, which may have an impact on the risk to develop 
IBD. Our data confirm long-term residence in an urban 
environment as a risk factor for IBD. Breastfeeding for <6 
Table 4. Multivariate analysis of the association between environmental risk factors and IBD before the age of 20
Outcome: IBD Outcome: CD Outcome: UC/IC
Any animals in household 0.929 (0.662–1.301) 1.019 (0.724–1.435) 0.687 (0.495–0.954)
p = 0.667 p = 0.914 p = 0.025
Cats or dogs in household 1.096 (0.808–1.487) 1.101 (0.812–1.493) 0.688 (0.510–0.930)
p = 0.555 p = 0.534 p = 0.015
Pet rodents in household 0.934 (0.689–1.264) 0.866 (0.639–1.173) 0.598 (0.437–0.817)
p = 0.657 p = 0.353 p = 0.001
Birds in household 1.737 (1.198–2.520) 1.399 (0.956–2.047) 1.671 (1.151–2.427)
p = 0.004 p = 0.084 p = 0.007
Reptiles in household 0.681 (0.311–1.490) 0.935 (0.454–1.922) 0.551 (0.240–1.264)
p = 0.336 p = 0.854 p = 0.159
Fish in household 1.054 (0.673–1.649) 1.191 (0.768–1.846) 0.793 (0.494–1.273)
p = 0.819 p = 0.435 p = 0.337
At least 10 years in urban areas >10,000 inhabitants 1.267 (0.878–1.829) 1.169 (0.761–1.794) 1.412 (0.888–2.244)
p = 0.206 p = 0.476 p = 0.144
Odds ratio, 95% confidence interval, and p values are reported. IBD, inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative 
colitis; IC, indeterminate colitis.
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months was associated with a lower risk of UC. The pres-
ence of various household animals especially within early 
life decreased the risk of IBD, especially in the UC sub-
group, while opposite effects of household birds were ob-
served.
The association between breastfeeding and IBD risk 
remains controversial [18–22, 30, 31]. Two meta-analyses 
support the hypothesis that breastfeeding is a protective 
factor for IBD [31, 32]. However, other studies observed 
that breastfeeding has no association with IBD or is even 
a risk factor for the development of the disease [33, 34]. 
Human milk contains, among others, lactoferrin, IgA, 
and lactadherin, which play an essential role in the de-
fense against early enteric infections [35]. Maternal milk 
also contains human milk oligosaccharides, a group of 
various sugars with prebiotic effects including Bifidobac-
teria growth, which would affect the intestinal microbio-
ta and may influence IBD risk [36]. In our study, we did 
not find a general effect of breastfeeding, but our data 
indicate an association of breastfeeding for <6 months 
with UC/IC. However, in our analysis, there was no in-
formation regarding breast milk substitution in any sub-
group available, and we were unable to correct for many 
relevant confounders. Furthermore, the number of pa-
tients who have been breastfed for >6 months is quite low, 
and our study would be underpowered to detect effects 
in this subgroup. Therefore, additional studies are 
warranted.
The association between C-section and IBD is also un-
der debate. A meta-analysis by Li et al. [26] implies an 
increased risk for CD but not for UC after C-section. On 
the other hand, a large population-based study of Bern-
stein et al. [27] reported no association of the mode of 
delivery with IBD. In our investigation, Cesarean delivery 
was also not associated with the risk for IBD. This is re-
markable in light of evidence indicating an impact of C-
section on the intestinal microbiota for up to 7 years of 
age [23]. However, investigations showed that differences 
in the intestinal flora of children delivered by C-section 
gradually diminish after the first year of life [25, 37].
The “hygiene hypothesis,” first published by Strachan 
[38], implied that the number of children in the house-
hold is inversely associated with the risk of hay fever and 
eczema. This theory has been extended to other immune-
mediated diseases such as IBD [14]. In line with the hy-
giene hypothesis, various risk factors related to microbial 
exposure such as exposure to household pets, farm ani-
mals, >2 siblings, sharing of bedrooms, or living in rural 
areas have been associated with protection from develop-
ing IBD [28, 39]. A higher exposure to pathobionts and 
microorganisms may lead to a better training of the im-
mune system and therefore a lower predisposition to de-
velop diseases with inappropriate immune activation 
[40].
Pets in the household would be one example for an EF 
related to increased microbial exposure and a protective 
effect of pets regarding IBD has been demonstrated [28, 
41, 42]. Our investigation also indicates a similar inverse 
association of household pets and the risk for IBD, espe-
cially of the UC/IC subtype. Interestingly, possession of 
birds in the household has opposite effects, increasing the 
chances of an IBD and UC/IC diagnosis. Further, for CD, 
neither pet animals in general nor any subspecies were 
associated with the disease. When only exposure to ani-
mals in young life, before the age of 20 was considered, 
we found a highly similar picture: pet rodents and cats or 
dogs in household were inversely associated with the risk 
of UC/IC but not CD, with birds increasing UC/IC risk. 
The reasons for differential effects of birds and other an-
imals and different susceptibility regarding the environ-
ment toward UC/IC and CD are unclear. Literature on 
this subject is rare, and we suggest further investigation 
with a bigger sample size and extended adjustment for 
confounders. In contrast to our findings, Castiglione et al. 
[43] reported no association of animals in household with 
CD and UC in a large case-control study. Another inves-
tigation from Han et al. [44] demonstrated even an in-
creased risk of CD when owing pets at home during child-
hood period.
A positive correlation between urban environment 
and the risk for IBD is well established and was corrobo-
rated by a meta-analysis [39]. In an urban environment, 
potential risk factors for IBD, for example, smoking, in-
take of antibiotics, or lack of helminths exposure, are 
more prevalent [45–47]. Furthermore, in urban areas, in-
frastructure and sanitation would be better, resulting in 
reduced exposure to enteric pathogens or pathobionts 
[48, 49]. Our data support these findings, and we report 
a statistically significant positive association between liv-
ing in urban areas and IBD. However, this association was 
not robust in the subanalysis regarding urban environ-
ment in young life. A possible explanation is the small 
sample size in this subgroup.
Our study has strengths as well as limitations. A 
strength is the large patient number in our cohort with 
1,111 returned questionnaires from IBD patients. Fur-
thermore, inclusion of 344 confirmatory questionnaires 
from patients’ mothers most likely reduced the “recall 
bias,” which is invariably present in any retrospective 
study.
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One limitation of our study is the low overall return of 
questionnaires (response rate for patients: 48.4%), poten-
tially resulting in a “reporting bias.” Response rates for 
the control group and for mothers were even lower (20.3 
and 27.5%, respectively). Therefore, the size of the control 
group (352 persons) was rather small compared to the 
larger patient group. Low response rates for the control 
group might be explained by the difficulty for patients to 
find 3 childhood friends who grew up in a similar envi-
ronment. Better strategies to increase sizes and coverage 
of friends and mothers cohorts are warranted for future 
studies. Probably further minimization of the effort to fill 
out questionnaires is needed. In addition to the printed 
questionnaires, the distribution of electronic question-
naires may increase the response rate and could be con-
sidered in further investigations. Obtaining a comparison 
between our control group and the baseline data of gen-
eral Swiss population has been difficult, considering that 
with a median age of 35, quality data especially regarding 
C-section and breastfeeding are needed from the 1980s. 
Therefore, we were not able to receive a clear evidence 
whether our data from the control group were affected by 
bias. Another limitation regards controlling for con-
founders. In our analyses, cases and controls were 
matched for sex and age, but we were unable to adjust for 
other potential confounders such as socioeconomic sta-
tus, place of residence, ethnicity, or education. Further-
more, we did not match for mode of delivery, breastfeed-
ing, and urbanism in our study. This might be relevant 
since, for instance, rates of C-sections or household ani-
mals would be different in urban compared to rural areas.
Appendix: Members of the Swiss IBD Cohort Study 
Group
Karim Abdelrahman, Gentiana Ademi, Patrick Aepli, 
Amman Thomas, Claudia Anderegg, Anca-Teodora An-
tonino, Eva Archanioti, Eviano Arrigoni, Diana Bakker 
de Jong, Bruno Balsiger, Polat Bastürk, Peter Bauerfeind, 
Andrea Becocci, Dominique Belli, José M. Bengoa, Luc 
Biedermann, Janek Binek, Mirjam Blattmann, Stephan 
Boehm, Tujana Boldanova, Jan Borovicka, Christian P. 
Braegger, Stephan Brand, Lukas Brügger, Simon Brun-
ner, Patrick Bühr, Bernard Burnand, Sabine Burk, Eman-
uel Burri, Sophie Buyse, Dahlia-Thao Cao, Ove Carstens, 
Dominique H. Criblez, Sophie Cunningham, Fabrizia 
D’Angelo, Philippe de Saussure, Lukas Degen, Joakim 
Delarive, Christopher Doerig, Barbara Dora, Susan Dre-
rup, Mara Egger, Ali El-Wafa, Matthias Engelmann, Jes-
sica Ezri, Christian Felley, Markus Fliegner, Nicolas 
Fournier, Montserrat Fraga, Yannick Franc, Pascal Frei, 
Remus Frei, Michael Fried, Florian Froehlich, Raoul Iva-
no Furlano, Luca Garzoni, Martin Geyer, Laurent Girard, 
Marc Girardin, Delphine Golay, Ignaz Good, Ulrike Graf 
Bigler, Beat Gysi, Johannes Haarer, Marcel Halama, Ja-
nine Haldemann, Pius Heer, Benjamin Heimgartner, 
Beat Helbling, Peter Hengstler, Denise Herzog, Cyrill 
Hess, Roxane Hessler, Klaas Heyland, Thomas Hinter-
leitner, Claudia Hirschi, Petr Hruz, Pascal Juillerat, Caro-
lina Khalid-de Bakker, Stephan Kayser, Céline Keller, 
Christina Knellwolf-Grieger, Christoph Knoblauch, 
Henrik Köhler, Rebekka Koller, Claudia Krieger-Grübel, 
Patrizia Künzler, Rachel Kusche, Frank Serge Lehmann, 
Andrew Macpherson, Michel H. Maillard, Michael Manz, 
Astrid Marot, Rémy Meier, Christa Meyenberger, Pame-
la Meyer, Pierre Michetti, Benjamin Misselwitz, Patrick 
Mosler, Christian Mottet, Christoph Müller, Beat Müll-
haupt, Leilla Musso, Michaela Neagu, Cristina Nichita, 
Jan Niess, Andreas Nydegger, Nicole Obialo, Diana Ollo, 
Cassandra Oropesa, Ulrich Peter, Daniel Peternac, Laeti-
tia Marie Petit, Valérie Pittet, Daniel Pohl, Marc Porzner, 
Claudia Preissler, Nadia Raschle, Ronald Rentsch, Alex-
andre Restellini, Sophie Restellini, Jean-Pierre Richt-
erich, Frederic Ris, Branislav Risti, Marc Alain Ritz, Ger-
hard Rogler, Nina Röhrich, Jean-Benoît Rossel, Vanessa 
Rueger, Monica Rusticeanu, Markus Sagmeister, Gaby 
Saner, Bernhard Sauter, Mikael Sawatzki, Michael Scharl, 
Martin Schelling, Susanne Schibli, Hugo Schlauri, Domi-
nique Schluckebier, Daniela Schmid, Sybille Schmid-Ue-
belhart, Jean-François Schnegg, Alain Schoepfer, Vivi-
anne Seematter, Frank Seibold, Mariam Seirafi, Gian-
Marco Semadeni, Arne Senning, Christiane Sokollik, 
Joachim Sommer, Johannes Spalinger, Holger Spangen-
berger, Philippe Stadler, Peter Staub, Dominic Stauden-
mann, Volker Stenz, Michael Steuerwald, Alex Strau-
mann, Bruno Strebel, Andreas Stulz, Michael Sulz, Au-
rora Tatu, Michela Tempia-Caliera, Joël Thorens, Kaspar 
Truninger, Radu Tutuian, Patrick Urfer, Stephan Vavric-
ka, Francesco Viani, Jürg Vögtlin, Roland Von Känel, 
Dominique Vouillamoz, Rachel Vulliamy, Paul Wiesel, 
Reiner Wiest, Stefanie Wöhrle, Samuel Zamora, Silvan 
Zander, Tina Wylie, Jonas Zeitz, and Dorothee Zimmer-
mann.
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